Episode

Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis

Podcast: The IMID Forum
Published: Jan 29, 2026
Duration seconds: 560
Processing state: not_requested
Canonical source: https://soundcloud.com/imidforum/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis
Audio: https://feeds.soundcloud.com/stream/2256465341-imidforum-discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis.mp3
JSON: /v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis
Markdown: /podcast/the-imid-forum-981476/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Strand et al. that evaluated TOF efficacy, safety, and persistence by sex, and explored whether age-related factors contribute to differences in treatment response between males and females, and by Alten et al. that explored the long‑term effectiveness of baricitinib and other b/tsDMARDs in patients with RA with early low disease activity or remission.